Business Wire - Sepracor and Arrow Sign Global License and Development Agreement Covering Technology to Enhance Ciclesonide and BROVANA® Franchises

Posted by admin / Under Arformoterol

May 1, 2008 -- * Agreement provides Sepracor with a global license covering development of stable suspension formulations and nebule technology in ciclesonide...

Published on Wednesday 8th of February 2012 01:06:58 PM

continue reading

Business Wire - Sepracor Inc. Announces the Establishment of a Unique Product-Specific Billing Code for BROVANA®

Posted by admin / Under Arformoterol

November 5, 2007 -- MARLBOROUGH, Mass. -- Sepracor Inc. (Nasdaq: SEPR) today announced that the Centers for Medicare and Medicaid Services (CMS) has established a...

Published on Wednesday 8th of February 2012 01:06:58 PM

continue reading

Business Wire - BROVANA™ Inhalation Solution Study Data Presented at American College of Chest Physicians Annual Conference

Posted by admin / Under Arformoterol

October 25, 2007 -- MARLBOROUGH, Mass. -- Sepracor Inc. (Nasdaq: SEPR) today announced that it presented safety and efficacy data from several studies of BROVANA([TM]...

Published on Wednesday 8th of February 2012 01:06:58 PM

continue reading

Business Wire - Sepracor Inc. Announces Second Quarter 2007 Results and Significant Milestone Events

Posted by admin / Under Arformoterol

July 27, 2007 -- Second Quarter and First Half 2007 Highlights

Second Quarter and First Half 2007 Highlights

* Quarterly total revenues increased 5.2%...

Published on Wednesday 8th of February 2012 01:06:58 PM

continue reading

Business Wire - BROVANA™ Inhalation Solution Now Available by Prescription for Patients with Chronic Obstructive Pulmonary Disease

Posted by admin / Under Arformoterol

April 11, 2007 -- MARLBOROUGH, Mass. -- Sepracor Inc. (Nasdaq: SEPR) today announced that BROVANA([TM]) brand arformoterol tartrate Inhalation Solution is now...

Published on Wednesday 8th of February 2012 01:06:58 PM

continue reading

Drug Store News - Sepracor

Posted by admin / Under Arformoterol

November 6, 2006 -- The Food and Drug Administration has approved an NDA for Brovana (arformoterol tartrate) Inhalation Solution 15 micrograms for chronic obstructive...

Published on Wednesday 8th of February 2012 01:06:58 PM

continue reading

Business Wire - BROVANA™ Inhalation Solution Study Data Presented at American College of Chest Physicians Annual Conference

Posted by admin / Under Arformoterol

October 23, 2006 -- BROVANA Recently Approved by U.S. Food & Drug Administration for the Long-Term Maintenance Treatment of Bronchoconstriction With COPD

...

Published on Wednesday 8th of February 2012 01:06:58 PM

continue reading

Business Wire - BROVANA™ Inhalation Solution Data to Be Presented at American College of Chest Physicians Annual Meeting

Posted by admin / Under Arformoterol

October 17, 2006 -- BROVANA Recently Approved by U.S. Food & Drug Administration for the Long-Term Maintenance Treatment of COPD

BROVANA Recently Approved by...

Published on Wednesday 8th of February 2012 01:06:58 PM

continue reading

Business Wire - FDA Approves Sepracor's BROVANA™ Inhalation Solution for Chronic Obstructive Pulmonary Disease

Posted by admin / Under Arformoterol

October 7, 2006 -- MARLBOROUGH, Mass. -- Sepracor Inc. (Nasdaq: SEPR) today announced that the U.S. Food and Drug Administration (FDA) approved its New Drug...

Published on Wednesday 8th of February 2012 01:06:58 PM

continue reading

Business Wire - Arformoterol Study Data Presented at European Respiratory Society Annual Congress

Posted by admin / Under Arformoterol

September 5, 2006 -- MARLBOROUGH, Mass. -- Sepracor Inc. (Nasdaq: SEPR) today announced that it presented a poster of pooled data from Phase III trials of arformoterol...

Published on Wednesday 8th of February 2012 01:06:58 PM

continue reading